Compugen (CGEN) Shareholder's Equity Growth (1y) (2010 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Compugen 234.03 Mn 142.28 Mn 352,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 87.08%
Sep 30, 2025 -27.55%
Jun 30, 2025 -13.86%
Mar 31, 2025 -4.30%
Dec 31, 2024 -16.24%
Sep 30, 2024 13.64%
Jun 30, 2024 -5.90%
Mar 31, 2024 -13.78%
Dec 31, 2023 -15.60%
Sep 30, 2023 -33.32%
Jun 30, 2023 -31.40%
Mar 31, 2023 -29.48%
Dec 31, 2022 -27.19%
Sep 30, 2022 -19.23%
Jun 30, 2022 -12.61%
Mar 31, 2022 -11.47%
Dec 31, 2021 -10.93%
Sep 30, 2021 -22.33%
Jun 30, 2021 -20.12%
Mar 31, 2021 -2.85%
Dec 31, 2020 212.58%
Sep 30, 2020 203.93%
Jun 30, 2020 307.19%
Mar 31, 2020 242.88%
Dec 31, 2019 2.89%
Sep 30, 2019 9.69%
Jun 30, 2019 -21.58%
Mar 31, 2019 9.46%
Dec 31, 2018 27.12%
Sep 30, 2018 0.44%
Jun 30, 2018 -14.14%
Mar 31, 2018 -45.48%
Dec 31, 2017 -53.88%
Sep 30, 2017 -45.99%
Jun 30, 2017 -38.78%
Mar 31, 2017 -32.72%
Dec 31, 2016 -29.34%
Sep 30, 2016 -21.31%
Jun 30, 2016 -19.16%
Mar 31, 2016 -17.89%
Dec 31, 2015 -15.28%
Sep 30, 2015 -15.90%
Jun 30, 2015 -2.77%
Mar 31, 2015 1.00%
Dec 31, 2014 232.78%
Sep 30, 2014 293.32%
Jun 30, 2014 373.73%
Mar 31, 2014 359.44%
Dec 31, 2013 80.44%
Sep 30, 2013 44.62%
Jun 30, 2013 -5.36%
Mar 31, 2013 2.36%
Dec 31, 2012 -9.75%
Sep 30, 2012 -15.81%
Jun 30, 2012 -15.22%
Mar 31, 2012 -21.04%
Dec 31, 2011 -30.77%
Sep 30, 2011 -17.34%
Jun 30, 2011 -1.97%
Mar 31, 2011 -5.96%
Dec 31, 2010 3.24%
Sep 30, 2010 185.97%
Jun 30, 2010 140.41%
Mar 31, 2010 221.38%